These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21329422)

  • 1. Proteomics and translational medicine: molecular biomarkers for cancer diagnosis, prognosis and prediction of therapy outcome.
    Cho WC
    Expert Rev Proteomics; 2011 Feb; 8(1):1-4. PubMed ID: 21329422
    [No Abstract]   [Full Text] [Related]  

  • 2. [The therapeutic contribution of proteomic approaches in cancers].
    Hamrita B; Nasr HB; Kabbage M; Hamann P; Kuhn L; Guillier C; Remadi S; Chaieb A; Khairi H; Chouchane L; Chahed K
    Gynecol Obstet Fertil; 2011 Feb; 39(2):87-93. PubMed ID: 21317010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive medicine: incipient reality or fata morgana?
    Dietel M
    J Pathol; 2007 Aug; 212(4):353-5. PubMed ID: 17573671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers in veterinary cancer screening: Applications, limitations and expectations.
    Henry CJ
    Vet J; 2010 Jul; 185(1):10-4. PubMed ID: 20510636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer proteomics and its application to discovery of therapy response markers in human cancer.
    Smith L; Lind MJ; Welham KJ; Cawkwell L;
    Cancer; 2006 Jul; 107(2):232-41. PubMed ID: 16752413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer biomarkers: current issues and future directions.
    Jain KK
    Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics: new technologies and clinical applications.
    Latterich M; Abramovitz M; Leyland-Jones B
    Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics and biomarkers for ovarian cancer diagnosis.
    Zhang B; Barekati Z; Kohler C; Radpour R; Asadollahi R; Holzgreve W; Zhong XY
    Ann Clin Lab Sci; 2010; 40(3):218-25. PubMed ID: 20689132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The footprints of cancer development: Cancer biomarkers.
    Ullah MF; Aatif M
    Cancer Treat Rev; 2009 May; 35(3):193-200. PubMed ID: 19062197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
    Peng XQ; Wang F; Geng X; Zhang WM
    Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment monitoring, recurrence detection, prognosis. Here's where tumor markers make good sense].
    Lamerz R; Stieber P
    MMW Fortschr Med; 2002 Oct; 144(41):26-8, 30-2. PubMed ID: 12474357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome informatics for cancer research: from molecules to clinic.
    Brusic V; Marina O; Wu CJ; Reinherz EL
    Proteomics; 2007 Mar; 7(6):976-91. PubMed ID: 17370257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in biomarkers for cancer diagnosis and treatment.
    Manne U; Srivastava RG; Srivastava S
    Drug Discov Today; 2005 Jul; 10(14):965-76. PubMed ID: 16023055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses.
    Voorzanger-Rousselot N; Garnero P
    Cancer Treat Rev; 2007 May; 33(3):230-83. PubMed ID: 17433551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
    Solassol J; Marin P; Maudelonde T; Mangé A
    Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for cancer risk, early detection, and prognosis: the validation conundrum.
    Brenner DE; Normolle DP
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1918-20. PubMed ID: 17932336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.